GTBP could be a potential buyout candidate imo....seems like the bigger companies like Celgene, Novartis, Gilead, etc are ALLLLL looking to pick up clinical stage companies involved in immunotherapy development
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.